Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Tumori|September 23, 2024
Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers?Jacopo Azzollini, Iolanda Capone, Matteo Duca, et al.
Neurology and Therapy|August 2, 2024
Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle ProjectDamiano Paolicelli, Giovanna Borriello, Raffaella Clerici, et al.
JCO Precision Oncology|June 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment RecommendationsFederico Nichetti, Marta Brambilla, Matteo Duca, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 14, 2019
Impact of natural menopause on multiple sclerosis: a multicentre studyDamiano Baroncini, Pietro Osvaldo Annovazzi, Nicola De Rossi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2025
Exploring the integration of patient-reported outcome measures in clinical practice: A cross-sectional survey of EORTC healthcare professionalsJens Lehmann, Tatiana Dragan, Elke Rammant, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 2, 2022
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective studyMatteo Gastaldi, Thomas Foiadelli, Giacomo Greco, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 6, 2024
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesisGiacomo Greco, Mario Risi, Stefano Masciocchi, et al.
JCO Precision Oncology|July 24, 2023
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient CareAndrea Vingiani, Luca Agnelli, Matteo Duca, et al.
Pageof 9